Ghrelin is a small endogenous peptide principally produced and secreted by the gastric mucosa, with a major role in appetite and metabolism regulation. We hypothesized that antiinflammatory therapy, as produced by exogenous administration of ghrelin, would decrease the myocardial inflammatory response to global hypothermia I/R, thereby affording myocardial protection. Heterotopic cervical heart transplantation that allows to subject donor hearts to global hypothermic ischemia and blood reperfusion, which very closely stimulates I/R conditions associated with cardiac surgical operations. Ghrelin administration prior to blood reperfusion significantly decreased serum concentrations of cTn-I versus animals subjected I/R alone, with a significantly attenuated VCAM-1 expression in I/R animals pretreated with ghrelin. The tissue concentrations of pro-inflammatory cytokines (IL-6, IL-1β, and MCP-1) were ameliorated by the administration of ghrelin prior to reperfusion versus the concentrations observed in animals subjected to I/R alone. Significantly fewer monocytes in the tissue sections of I/R+ghrelin animals versus those subjected to I/R alone. Exogenous ghrelin administration prior to reperfusion of an ischemic heart resulted in a significant reduction in myocardial injury as measured by cTn-I. The reduced myocardial injury was accompanied by an attenuated tissue expression of several pro-inflammatory mediators including VCAM-1, IL-6, IL-1β, and MCP-1.
Introduction
Cardiac surgery with cardiopulmonary bypass induces a myocardial inflammatory response characterized by increased expression of proinflammatory cytokines and chemokines [1] ; this response contributes to myocardial injury associated with the obligatory global myocardial ischemia and reperfusion (I/R) [2] . However, reperfusion of ischemic heart can induce myocardial injury and this injury can be further exacerbating during open-heart surgery when the myocardium is exposed global ischemic cardioplegic arrest [3] . Myocardial reperfusion injury activates neutrophils [4] , which trigger an inflammatory response resulting in generation of reactive oxygen species (ROS), cytokine release, and complement activation which further induce more cardiac injury [5, 6] . In addition to the inflammatory response generated because of tissue reperfusion injury, there is a significant systemic inflammatory response that is triggered by cardiopulmonary bypass (CPB) during open-heart surgery.
Several anti-inflammatory techniques and pharmacological agents (largely aimed at coping with CPB) have been used in recent years in cardiac surgery; these include leukocyte filtration, corticosteroids, heparin [7, 8] . Despite the relatively small number of studies investigating the effects of reducing the inflammatory response to myocardial reperfusion injury, the majority of these studies has shown evidence of myocardial protection [9] . Ghrelin is an orexigenic hormone identified as an endogenous ligand for the growth hormone secretagogue receptor (GHSR) and discovery after of the growth hormone secretagogue type 1A receptor in 1996 [10] and was reported by Masayasu Kojima and colleagues in 1999 as peptide of 28 amino acids in rat and human stomachs [11] . Ghrelin levels increase before meals and decrease after meals. In addition, smaller amounts of ghrelin is also produced by other organs, such as heart, lung, kidney, pancreas, placenta, lymphatic tissue, gonads, thyroid, adrenal, pituitary, hypothalamus [12, 13] .
Recent research has shown that there is an association between systemic ghrelin levels and cardiovascular indexes [14] , in one study showed that ghrelin can dose-dependently increase coronary perfusion pressure in isolated perfuse rat hearts and constrict isolated coronary arterioles, and this coronary vasoconstrictive action is dependent on Ca 2+ and protein kinase C (PKC) [15] . In vitro a study, ghrelin has shown to prevent against the cardiotoxicity of adriamycin may be attributed to up regulation of TNF-α/NF-κB pathways, as well as its mitochondrial stabilization properties [16] . A study reported that, in anesthetized pigs, intracoronary infusion of ghrelin induced coronary artery contraction, thereby reducing coronary circulation and the mechanism of this response has been shown to involve the inhibition of beta 2-adrenergic mediated release of NO [17] . Thus, the exact ghrelin effects on coronary perfusion are inconclusive at present. Nonetheless, the beneficial effects of ghrelin on the isolated I/R heart may yet indicate a potential role for this peptide in prevention of I/R injury.
The purpose of our study is to use a syngeneic murine model to evaluate ghrelin's antiinflammatory and cardio-protective potential. To accomplish these tasks:
 We planned to assess the degree of myocardial injury following I/R by measuring serum levels of the well known cardiac injury marker troponin-I.
 To determine if anti-inflammatory mechanisms are involved we planned to measure tissue levels of the known pro-inflammatory mediators (MCP-1, IL-1β, IL-6, and VCAM-1).
 Evaluating the degree of leukocyte infiltration into the myocardium. 
Methods and materials

Animals
Heterotopic heart transplantation
Heterotopic heart transplantation was performed in adult WT C3H/HeN mice as previously described by others [18] , [19] . In brief, grafting TLR4 mutant donor hearts were arrested with cold St. Thomas crystalloid cardioplegic; rapidly prepared for transplantation.
Heart preparation entailed ligating all great vessels proximal, excluding the ascending aorta.
Following isolation donor hearts were subjected to 4-hrs cold ischemia at 4˚C. Plasma from these donor animals was harvested prior to cardioplegic arrest and used for baseline analysis. 
Western blotting was performed for the myocardial adhesion molecule VCAM-1.
Using NIH imaging software to normalize band densities of VCAM-1 to the loading control protein GAPDH, we observed a significantly attenuated VCAM-1 expression in I/R animals pre-treated with ghrelin versus those subjected to I/R alone. Data are expressed as mean±SEM. n=8 in each group; * P<0.05 vs. I/R without ghrelin treatment group. 
Ghrelin attenuated VCAM-1 expression after global I/R
Discussion
Ghrelin is an important hormone in regulating energy metabolism in the body. Studies have shown that ghrelin may have beneficial effects on left ventricular function and energy metabolism in CHF through GH-dependent mechanisms due to the hemodynamic and anabolic effects of GH/IGF-1 [21] . Besides having a stimulatory effect on GH secretion, ghrelin administration was shown to induce positive energy balance by stimulating food intake while decreasing fat use through GH-independent mechanisms [22] . Moreover, recent studies suggest that ghrelin possesses a variety of cardiovascular effects independent of GH secretion, including increases in myocardial contractility, vasodilation and protection from heart failure induced by myocardial infarction or septic shock in vivo [23] .
Nagaya [24] previously reported that subcutaneous administration of ghrelin improves LV dysfunction and attenuates the development of LV remodeling in rats with chronic heart failure. In addition, a recent ex vivo study has shown that the administration of ghrelin during ischemia-reperfusion protects against myocardial injury, and this effect involves binding to cardiovascular receptors; a process that is up regulated during ischemia reperfusion [25] .
However, still the mechanisms whereby ghrelin improves myocardial function and metabolism after I/R are unclear.
In this study, administration of exogenous ghrelin prior to reperfusion of transplant heart resulted in a significant reduction in myocardial injury identified by decreased serum Troponin-I level compared with mice subjected to cold I/R alone. Furthermore, our result has been demonstrated that the inflammatory response after cold I/R is reduced after ghrelin treatment in form of mediated by suppression of several pro-inflammatory mediators;
including VCAM-1, IL-6, IL-1β, and this may explain how the ghrelin protected the myocardium after global hypothermia I/R. While, Locatelli et al showed that administration of ghrelin inhibited myocardial MDA generation in a concentration-dependent manner, suggesting that ghrelin could potentially inhibit oxidative injury by acting as an antioxidant and/or by inhibiting the production of reactive oxygen species during reperfusion [26] . Production of reactive oxygen species during reperfusion is thought to be a major mediator of I/R injury, and other study suggesting that ghrelin might exert cardiovascular effects through mechanisms distinct from stimulation of GH release [27] .
We have recently demonstrated that hypothermia myocardial I/R in wild type mice exhibit an active inflammatory reaction, associated with MCP-1 up regulation and leukocyte through vagal nerve stimulation prevented the down-regulatory effects of ghrelin on inflammatory cytokines in sepsis, they suggest that the intact vagus nerve is essential to the inhibitory effect of ghrelin on the release of proinflammatory cytokines [29] . While others is suggested that ghrelin induced a marked increase in serum GH levels (15-fold), which was associated with slight increases in circulating epinephrine, adrenocorticotropin, cortisol and prolactin lead to beneficial haemodynamic effects in patients with CHF inform of significantly increased cardiac index and stroke volume index however; it did not alter mean pulmonary arterial pressure or pulmonary capillary wedge pressure, in the absence of renal effects [30] .
Conclusion
Administration of exogenous ghrelin prior to reperfusion of an ischemic heart resulted in a significant reduction in myocardial injury as measured by cTn-I. The reduced myocardial injury was accompanied by an attenuated tissue expression of several pro-inflammatory mediators; including IL-6, IL-1β, MCP-1 and adhesion molecule VCAM-1. Additionally, we observed that there is significantly less monocytes infiltration in the myocardium after ghrelin treated animals versus those subjected to I/R alone.
